Researcher
Karel Fostier
- Keywords:Medicine
Affiliations
- Hematology (Research group)
Member
From22 Mar 2021 → Today - Hematology (Department)
Member
From1 Jan 2013 → Today - Hematology (Department)
Member
From1 Feb 2019 → 13 Feb 2022 - Faculty of Medicine and Pharmacy (Faculty)
Member
From22 Jun 2017 → 7 Sep 2017 - Basic (bio-) Medical Sciences (Department)
Member
From1 Dec 2015 → 30 Nov 2017 - Basic (bio-) Medical Sciences (Department)
Member
From1 Dec 2015 → 2 Dec 2015 - Internal medicine (Department)
Member
From1 Sep 2010 → 31 Dec 2012 - Internal medicine (Department)
Member
From1 Jul 2009 → 31 Aug 2009 - Physiology (Department)
Member
From1 Oct 2006 → 30 Jun 2009 - Physiology (Department)
Member
From1 Oct 2006 → 30 Jun 2009 - Laboratory of Molecullar and Cellular Therapy (Research group)
Member
From1 Sep 2006 → 19 Mar 2021
Publications
1 - 10 of 24
- Validation of a PCR-based next-generation sequencing approach for the detection and quantification of minimal residual disease in acute lymphoblastic leukemia and multiple myeloma using gBlocks as calibrators(2021)
Authors: Jona Van der Straeten, Wouter De Brouwer, Emmanuelle Kabongo Kanjinga, Marie-Françoise Dresse, Karel Fostier, Henri Schots, Ivan Van Riet, M.H.C. Bakkus
Pages: 599-611 - COVID-19, impact on myeloma patients(2020)
Authors: Inès Dufour, Juliette Raedemaeker, Fabio Andreozzi, Géraldine Verstraete, Sarah Bailly, Michel Delforge, Pauline Storms, Caroline Jacquy, Ann Van de Velde, Philippe Mineur, et al.
Pages: 1947-1949 - Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients(2019)
Authors: Eileen M Boyle, Xavier Leleu, Marie-Odile Petillon, Lionel Karlin, Chantal Doyen, Hélène Demarquette, Bruno Royer, Margaret Macro, Philippe Moreau, Karel Fostier, et al.
Pages: 319-327 - Antigen excess detection by automated assays for free light chains(2018)
Authors: Xavier Bossuyt, Michel Delforge, Martin Reynders, Doreen Dillaerts, Ben Sprangers, Karel Fostier, Koen Poesen, Martine Vercammen
Pages: E235-E238 - Long-term disease control of Langerhans cell histiocytosis using combined BRAF and MEK inhibition(2018)
Authors: Gil Awada, Teofila Seremet, Karel Fostier, Hendrik Everaert, Bart Neyns
Pages: 2156-2158 - Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used(2018)
Authors: Xavier Bossuyt, Michel Delforge, Martin Reynders, Doreen Dillaerts, Ben Sprangers, Karel Fostier, Koen Poesen, Martine Vercammen
Pages: 1815-1818 - Child-onset thrombotic thrombocytopenic purpura caused by p.R498C and p.G259PfsX133 mutations in ADAMTS13(2018)
Authors: An-Sofie Schelpe, Christelle Orlando, Bogaç Ercig, Chloë Geeroms, Inge Pareyn, Nele Vandeputte, Leydi Carolina Velásquez Pereira, Elien Roose, Karel Fostier, Gerry A F Nicolaes, et al.
Pages: 191-199 - Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation(2018)
Authors: Karel Fostier, Jo Caers, Nathalie Meuleman, Jurgen Corthals, Brenda De Keersmaecker
Pages: 20476-20489 - Extracellular S100A9 protein in bone marrow supports multiple myeloma survival by stimulating angiogenesis and cytokine secretion(2017)
Authors: Kim De Veirman, Nathan De Beule, Ken Maes, Eline Menu, Elke De Bruyne, Hendrik De Raeve, Karel Fostier, Jerome Moreaux, Alboukadel Kassambara, Dirk Hose, et al.
Pages: 839-846 - Bone Marrow Metastases from a 1p/19q Co-deleted Oligodendroglioma - A Case Report(2016)
Authors: Marieke Demeulenaere, Stephanie Du Four, Karel Fostier
Pages: 4145-4149